Vaughan Nelson Investment Management L.P. Raises Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Vaughan Nelson Investment Management L.P. raised its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 40.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 436,880 shares of the company’s stock after purchasing an additional 126,220 shares during the quarter. Vaughan Nelson Investment Management L.P. owned approximately 0.47% of Acadia Healthcare worth $34,610,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Fifth Third Bancorp lifted its holdings in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares during the last quarter. Tranquility Partners LLC lifted its holdings in shares of Acadia Healthcare by 5.3% in the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock worth $264,000 after buying an additional 170 shares in the last quarter. GAMMA Investing LLC purchased a new stake in shares of Acadia Healthcare in the fourth quarter worth about $26,000. Treasurer of the State of North Carolina lifted its holdings in shares of Acadia Healthcare by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 39,776 shares of the company’s stock worth $3,093,000 after buying an additional 390 shares in the last quarter. Finally, Retirement Systems of Alabama lifted its holdings in shares of Acadia Healthcare by 0.4% in the fourth quarter. Retirement Systems of Alabama now owns 115,496 shares of the company’s stock worth $8,981,000 after buying an additional 409 shares in the last quarter.

Acadia Healthcare Stock Down 1.3 %

Shares of NASDAQ ACHC opened at $66.12 on Wednesday. Acadia Healthcare Company, Inc. has a one year low of $62.04 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The firm’s 50 day simple moving average is $68.28 and its two-hundred day simple moving average is $75.72. The stock has a market capitalization of $6.13 billion, a P/E ratio of -472.25, a PEG ratio of 2.03 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. During the same period last year, the business earned $0.75 earnings per share. The business’s quarterly revenue was up 9.1% on a year-over-year basis. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 3.52 EPS for the current fiscal year.

Analyst Ratings Changes

ACHC has been the topic of a number of recent analyst reports. Bank of America lowered their price target on shares of Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday. TD Cowen decreased their price objective on shares of Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating on the stock in a research report on Friday, May 17th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price objective on the stock in a research report on Thursday, April 25th. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and a consensus target price of $87.56.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.